Clinical Trials Directory

Trials / Sponsors / Ocugen

Ocugen

Industry · 11 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Active Not RecruitingA Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa
Retinitis Pigmentosa
Phase 32024-06-18
RecruitingPhase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Center Involved Diabetic Macular Edema, Diabetic Macular Edema
Phase 12024-01-13
Active Not RecruitingA Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease
Stargardt Disease
Phase 2 / Phase 32023-08-25
Active Not RecruitingStudy to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy
Geographic Atrophy
Phase 1 / Phase 22023-02-23
UnknownImmuno-bridging and Broadening Study of a Whole, Inactivated COVID-19 Vaccine BBV152 in Healthy Adults
COVID-19
Phase 2 / Phase 32022-02-20
Active Not RecruitingStudy to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis
Retinitis Pigmentosa, Leber Congenital Amaurosis
Phase 1 / Phase 22022-01-24
TerminatedStudy of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease
Graft Versus Host Disease, Ocular Surface Disease, oGVHD
Phase 32018-12-23
CompletedStudy of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)
Dry Eye
Phase 32018-12-03
CompletedDry Eye Disease Study With Brimonidine
Dry Eye
Phase 22017-09-06
No Longer AvailableExpanded Access Program of Whole, Inactivated COVID-19 Vaccine COVAXIN™ (BBV152) in Adults Aged 18 Years and O
COVID-19
——
No Longer AvailableExpanded Access Program for RP in Adults
Retinitis Pigmentosa
——